News
HSBC upgraded Dr. Reddy’s Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from ...
She added that HR did nothing even after she reported it. An HSBC employee took to LinkedIn to share a post to document the alleged discrimination she faced at her workplace. She claimed that she ...
Fintel reports that on June 5, 2025, HSBC upgraded their outlook for Dr. Reddy's Laboratories Limited - Depositary Receipt () ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results